Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-24T17:44:30.367Z Has data issue: false hasContentIssue false

Psychiatry and the pharmaceutical industry

Published online by Cambridge University Press:  02 January 2018

Rights & Permissions [Opens in a new window]

Abstract

Type
Papers
Copyright
Copyright © Royal College of Psychiatrists 2009 

Little Pharma made profits by making novel compounds; Big Pharma does it by marketing. Doctors say they consume (prescribe) medication according to the evidence, so marketeers design and run trials to increase a drug's use. They select the trials, data and authors that suit, publish in quality journals, facilitate incorporation in guidelines, then exhort doctors to practise evidence-based medicine. Because ‘they're worth it’, doctors consume branded high-cost but less effective ‘evidence-based’ derivatives of older compounds making these drugs worth more than their weight in gold. Posted parcels meanwhile are tracked far more accurately than adverse treatment effects on patients.

Submit a response

eLetters

No eLetters have been published for this article.